4.7 Letter

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control

期刊

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 329, 期 12, 页码 1024-1026

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2023.0492

关键词

-

向作者/读者索取更多资源

This clinical trial investigated the risk of disease activity flares in rheumatoid arthritis patients who discontinued csDMARDs compared to those who continued with half-dose csDMARDs. The trial was open-label and randomized, and the follow-up period was 12 months.
This open-label randomized clinical trial assessed the 12-month risk of disease activity flares after discontinuation of conventional synthetic DMARDs (csDMARDs) compared with continuing half-dose csDMARDs in adult Norwegian patients with rheumatoid arthritis and excellent disease control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据